This book includes a plain text version that is designed for high accessibility. To use this version please follow this link.
16


nanotimes


Companies Facts


Moreover, at MEDTEC Europe, Bayer MaterialScience presented e.g. Baymedix®


brand hydrophilic prepo-


lymers, which are used to manufacture polyuretha- ne foams for medical wound dressings. The foams absorb aqueous liquids and retain them better than conventional foams. They can be combined with Platilon®


thermoplastic polyurethane films, which


are water vapor permeable and allow wounds to bre- athe. One example is Bayblend®


M850XF, a blend


of polycarbonate and acrylonitrile-butadiene-styrene that is very well suited for the production of housings for medical equipment. This includes primarily surgical instruments, diagnostic equipment and drug administration systems.


http://www.materialscience.bayer.com http://www.radcoinfusion.com/led


primary human cell biology were presented at the annual meeting of the Society of Toxicology by scien- tists from the US Environmental Protection Agency and BioSeek, LLC. The presented findings further demonstrate the value of BioMAP®


A human primary


cell assay systems for both identifying critical bioac- tivities and potentially adverse effects of drugs, new materials and other compounds in a high-throughput format. BioSeek, LLC, is a wholly owned subsidiary of Aste- rand plc. (OTCBB: ATDPF).


http://www.asterand.com http://www.bioseekinc.com


ssessments of the biological activity of various nanomaterials and chemicals in the context of


Based in Livermore, California, Bridgelux is a pioneer in solid-state lighting (SSL), expanding the market for light-emitting diode (LED) technologies by driving down the cost of LED lighting systems. Bridgelux’s patented light source technology replaces traditional technologies (such as incandescent, halogen, fluo- rescent and high intensity discharge lighting) with integrated, solid-state lighting solutions that enable lamp and luminaire manufacturers to provide high performance and energy-efficient white light for the rapidly growing interior and exterior lighting mar- kets, including street lights, commercial lighting and consumer applications.With more than 600 patent applications filed or granted worldwide, Bridgelux is the only vertically integrated LED manufacturer and developer of solid-state light sources that designs its solutions specifically for the lighting industry. For more information about the company, please visit


http://www.bridgelux.com B


ruker Corporation (NASDAQ: BRKR) reported financial results for the fourth quarter and year


ended December 31, 2011. In the fourth quarter of 2011, revenue was $475.1 million, compared to $416.1 million in the fourth quarter of 2010, an in- crease of 14.2%, including a 1.7% currency tailwind.


B


ridgelux Inc., a developer and manufacturer of LED lighting technologies and solutions, an-


nounced that Kaistar Lighting (Xiamen) Co., Ltd.has agreed to invest $25 million in the company. Bridge- lux will use the equity investmentto further accele- rate research, development, and production of LED chip and packaging technology for general illuminati- on applications.


12-02 :: February/March 2012


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89